In order to tailor the site to your needs, please click the button that relates best to you.
So long as you have cookies enabled you will only need to do this once. However, you can change your selection at any time using the dropdown navigation option above the CESPHN logo, top left.
Cervical cancer is almost entirely preventable – but screening is vital. Around 80 per cent of Australian women who develop cervical cancer do not get screened regularly as recommended, or have never been screened.
Important information for healthcare professionals – Expansion of self-collection for cervical screening –
From Friday 1 July 2022, the National Cervical Screening Program (NCSP) has expanded screening test options, now offering self-collection of a vaginal sample as a choice to all people participating in cervical screening.
Attached are key messages to help you to understand what these changes mean for you and your practice/clinic and how to work with the Pathology laboratory that processes your tests. It would be appreciated if you could disseminate this throughout your networks. You can also find a link to the key messages on our website.
A range of resources to help you promote self-collection and support your discussions with your clients, in particular Aboriginal women and is available from the National Cervical Screening Program website:
In addition to the above resources, a video interview and FAQs for healthcare providers supporting the updates to the clinical guidelines are now available through Cancer Council Australia.
National Cervical Screening Program Clinical Guidelines: Important changes for women at intermediate risk:
In light of new evidence, changes to the NCSP’s Guidelines for the clinical management of women at intermediate risk will come into effect from 1 February 2021. This follows the Cancer Council Australia Clinical Guidelines review of national data from the renewed program.
It is now recommended that women with a 12-month follow up HPV (not-16/18) result with LBC prediction negative, pLSIL or LSIL (intermediate risk result) should be recommended to undertake a further HPV follow up test in 12 months’ time following their previous HPV test instead of referral to colposcopy.
Further information about the changes and the revised cervical screening pathway flowchart is now on the NCSP website.
The National Cervical Screening Program Guidelines for 1 December 2017 onwards, can now be accessed at the Cancer Council Australia website.
Education and Training courses for GPs and practice nurses can be found at Family Planning NSW.
The Pathology Test Guide for Cervical and Vaginal testing provides context for using the variations of cervical screening and shows what to write on the pathology request form on the Dept of Health website.
Understanding the National Cervical Screening Program Management Pathway: a guide for health professionals is also a useful reference to help ensure the correct test is requested from the Dept of Health website.
A comprehensive summary of information about the Renewal of the National Cervical Screening Program, resources for patients and where to go for more details can be found at the Cancer Institute NSW
Screening with a disability – Cervical, breast and bowel screening is important for all people, but we know that people with intellectual disability are not screened as often as they should. FPNSW have produced screening resources for people with an intellectual disability.
Central and Eastern Sydney PHN have moved to a new site.
As you may have noticed, our website looks different. Central and Eastern Sydney PHN have moved to a new site and although much has remained the same, we have introduced some new functions.
Welcome to our new website! As you may have noticed, our website looks different. Central and Eastern Sydney PHN have moved to a new site and although much has remained the same, we have introduced some new functions. These include: Updated navigation When you land on our new website, you…
Immunisation weekly update – 8 February 2023 HPV vaccination now single dose on NIP Changes from 6 February 2023 to human papillomavirus vaccination (Gardasil®9) dose schedule under the National Immunisation Program: Routine schedule for people aged 12 to 13 years will change to a single dose (previously a 2 dose…
Sydney World Pride 2023 – General Practice Support CESPHN is a proud supporter of the Sydney WorldPride 2023 that is occurring from 17 February to 5 March 2023. To assist people to get the right care and avoid unnecessary presentations to emergency departments, we are encouraging general practices to review…
COVID-19 weekly update – 08 JANUARY 2023 ATAGI 2023 Booster Advice The Australian Technical Advisory Group on Immunisation (ATAGI) have updated their recommendations on the use of booster doses of COVID-19 vaccine in 2023. ATAGI recommends a 2023 COVID-19 vaccine booster dose for adults in the following groups, if their…
MEDIA RELEASE: Canterbury Head to Health service opens doors to offer free, immediate mental health support. Canterbury Head to Health opened its doors in late January, offering free and immediate support for anyone in Canterbury and the surrounding regions experiencing distress or mental health concerns.Trained professionals are providing short to…
CESPHN Vax at Home service The CESPHN Vax at Home Service is for those people who are housebound and not able to leave their house to receive a COVID-19 vaccination or booster. The service will accept referrals for people 16 years and over. Referrals will be accepted from GPs and…
IAR-DST Training resumes today The implementation of the Initial Assessment and Referral Decision Support Tool (IAR-DST) training is gaining momentum both within CESPHN and nationally. National GP training numbers are closing in on 300 and over 50 of these have been trained by CESPHN. This year we are excited to…